185 related articles for article (PubMed ID: 36603533)
1. Analysis of HIV-1 envelope cytoplasmic tail effects on viral replication.
Alfadhli A; Romanaggi C; Barklis RL; Barklis E
Virology; 2023 Feb; 579():54-66. PubMed ID: 36603533
[TBL] [Abstract][Full Text] [Related]
2. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.
Alfadhli A; Romanaggi C; Barklis RL; Barklis E
J Virol; 2024 Feb; 98(2):e0174223. PubMed ID: 38193694
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
Waheed AA; Ablan SD; Roser JD; Sowder RC; Schaffner CP; Chertova E; Freed EO
Proc Natl Acad Sci U S A; 2007 May; 104(20):8467-71. PubMed ID: 17483482
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.
Durham ND; Chen BK
J Virol; 2015 Sep; 89(18):9324-37. PubMed ID: 26136566
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
[TBL] [Abstract][Full Text] [Related]
6. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
[TBL] [Abstract][Full Text] [Related]
7. Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.
Wang XF; Wang YH; Bai B; Zhang M; Chen J; Zhang X; Gao M; Wang X
J Virol; 2021 Nov; 95(23):e0108721. PubMed ID: 34495693
[TBL] [Abstract][Full Text] [Related]
8. Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4
Fernandez-de Céspedes MV; Hoffman HK; Carter H; Simons LM; Naing L; Ablan SD; Scheiblin DA; Hultquist JF; van Engelenburg SB; Freed EO
J Virol; 2022 Dec; 96(23):e0087622. PubMed ID: 36354340
[TBL] [Abstract][Full Text] [Related]
9. Reverted HIV-1 Mutants in CD4
Lu W; Li TW; Phillips S; Wu L
Microbiol Spectr; 2021 Dec; 9(3):e0165321. PubMed ID: 34935422
[TBL] [Abstract][Full Text] [Related]
10. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.
Qi M; Chu H; Chen X; Choi J; Wen X; Hammonds J; Ding L; Hunter E; Spearman P
Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7575-80. PubMed ID: 26034275
[TBL] [Abstract][Full Text] [Related]
11. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail.
Fernandez MV; Hoffman HK; Pezeshkian N; Tedbury PR; van Engelenburg SB; Freed EO
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938764
[TBL] [Abstract][Full Text] [Related]
13. Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.
Staubus AO; Alfadhli A; Barklis RL; Barklis E
Virology; 2019 Dec; 538():1-10. PubMed ID: 31550607
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle.
Van Duyne R; Kuo LS; Pham P; Fujii K; Freed EO
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9040-9049. PubMed ID: 30975760
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 replication.
Freed EO
Somat Cell Mol Genet; 2001 Nov; 26(1-6):13-33. PubMed ID: 12465460
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
17. A Conserved Tryptophan in the Envelope Cytoplasmic Tail Regulates HIV-1 Assembly and Spread.
Snetkov X; Haider T; Mesner D; Groves N; van Engelenburg SB; Jolly C
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062333
[TBL] [Abstract][Full Text] [Related]
18. The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.
Santos da Silva E; Mulinge M; Lemaire M; Masquelier C; Beraud C; Rybicki A; Servais JY; Iserentant G; Schmit JC; Seguin-Devaux C; Perez Bercoff D
PLoS One; 2016; 11(9):e0161596. PubMed ID: 27598717
[TBL] [Abstract][Full Text] [Related]
19. Effect of extension of the cytoplasmic domain of human immunodeficiency type 1 virus transmembrane protein gp41 on virus replication.
Chan WE; Wang YL; Lin HH; Chen SS
J Virol; 2004 May; 78(10):5157-69. PubMed ID: 15113898
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants.
Waheed AA; Ablan SD; Mankowski MK; Cummins JE; Ptak RG; Schaffner CP; Freed EO
J Biol Chem; 2006 Sep; 281(39):28699-711. PubMed ID: 16882663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
